XML 14 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
REVENUES $ 4,553 $ 2,889
COST OF REVENUES (2,924) (2,088)
GROSS PROFIT 1,629 801
RESEARCH AND DEVELOPMENT EXPENSES [1] (7,286) (5,967)
Less - grants 843 1,338
RESEARCH AND DEVELOPMENT EXPENSES, NET (6,443) (4,629)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES [1] (2,498) (2,537)
OPERATING LOSS (7,312) (6,365)
FINANCIAL EXPENSES (2,220) (2,087)
FINANCIAL INCOME 132 1,625
LOSS FROM CHANGE IN FAIR VALUE OF CONVERTIBLE NOTES embedded derivative   (52,321)
FINANCIAL (EXPENSES) INCOME, NET (2,088) (52,783)
LOSS FOR THE PERIOD $ (9,400) $ (59,148)
NET LOSS PER SHARE OF COMMON STOCK - BASIC AND DILUTED $ (0.06) $ (0.48)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - BASIC AND DILUTED 145,305,982 124,467,602
[1] Includes share-based compensation